Why the study?
To determine if not using residual neuromuscular blockade analysis to guide neuromuscular blockade reversal administration in the postsurgical ICU results in consequences related to residual weakness.
Does reversing neuromuscular blockade without nerve stimulator guidance result in consequences related to residual weakness in postcardiac surgical ICU patients?
Does reversing neuromuscular blockade without nerve stimulator guidance result in consequences related to residual weakness in postcardiac surgical ICU patients?
Reversing neuromuscular blockade without nerve stimulator guidance in a postcardiac surgical ICU resulted in unrecognized residual weakness in a small minority of patients, though ICU-level care may mitigate severe consequences.
Without RNB guidance, reversal may leave residual weakness; leaves open whether quantitative monitoring improves outcomes in postcardiac surgical ICU.
We aimed to determine if not using residual neuromuscular blockade (RNB) analysis to guide neuromuscular blockade reversal administration in the postsurgical ICU resulted in consequences related to residual weakness. This single-center, prospective study evaluated 104 patients arriving in a postcardiac surgical ICU. After demonstrating spontaneous movement and T > 35.5 °C, all patients underwent RNB evaluation, and neostigmine/glycopyrrolate was then administered. When patients later demonstrated an adequate Rapid Shallow Breathing Index, negative inspiratory force generation, and arterial blood gas values with minimal mechanical ventilatory support, RNB evaluation was repeated in 94 of the 104 patients, and all patients were extubated. Though RNB evaluation was performed, patients were extubated without considering these results. Eleven of one hundred four patients had not achieved a Train-of-Four (TOF) count of four prior to receiving neostigmine. Twenty of ninety-four patients demonstrated a TOF ratio ≤ 90% prior to extubation. Three patients received unplanned postextubation adjunct respiratory support-one for obvious respiratory weakness, one for pain-related splinting compounding baseline disordered breathing but without obvious benefit from BiPAP, and one for a new issue requiring surgery. Residual neuromuscular weakness may have been unrecognized before extubation in 1 of 104 patients administered neostigmine without RNB analysis. ICU-level care may mitigate consequences in such cases.
No takes yet. Share an insight, caveat, or question.
Calef et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: